The levels of APP associated with brain‐isolated mitochondria, albeit lower in the GMP‐1‐treated group, did not reach statistical significance (Figure 5 C).
← all excerpts
Development of GMP-1 a molecular chaperone network modulator protecting mitochondrial function and its assessment in fly and mice models of Alzheimer's disease.
1
—
—